Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers. - Test2 - elhamkhani - TriplyDB

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers.

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers.

http://www.wikidata.org/entity/Q37669469

about

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers.

http://www.wikidata.org/entity/Q37669469

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Medico-economic impact of MSKC ...... HER2-negative breast cancers.

@en

Medico-economic impact of MSKC ...... HER2-negative breast cancers.

@nl

type

label

Medico-economic impact of MSKC ...... HER2-negative breast cancers.

@en

Medico-economic impact of MSKC ...... HER2-negative breast cancers.

@nl

prefLabel

Medico-economic impact of MSKC ...... HER2-negative breast cancers.

@en

Medico-economic impact of MSKC ...... HER2-negative breast cancers.

@nl

P1433

Q37669469-B84294AE-DB94-4DFD-BDE3-7BB1D47C3C07

P1476

Q37669469-33540A64-427E-4553-9678-2EB039A2FE1A

P2093

Q37669469-1DF21F98-3DF5-4178-B695-A18E19348CF5

Q37669469-2ECC23A6-E01F-4DE8-9AAF-E1E947856DDB

Q37669469-30ED9809-3EF9-4382-9C08-C84FE1B96BFA

Q37669469-321178C7-F42A-4552-A4C4-858B86613CD3

Q37669469-407E0DC0-09FF-4F0B-9181-CCCAAC7E4AF4

Q37669469-9BE1FAFC-305A-4C30-AE9D-2F18A31ED2C7

Q37669469-9C3668CC-1AC7-4B56-BF19-1D067D600D34

Q37669469-A2AC63E2-EA6B-482C-B528-D4DDC2ED8C11

Q37669469-B2FE5C5E-6190-489A-B9FE-39FA9BDA8DC2

Q37669469-B9D4DBD4-4EAD-4568-B218-C4E96F4AEDD2

P2860

Q37669469-0D38D903-8C97-49E5-B4BE-235CB5AA5605

Q37669469-1043E31A-EA9F-441C-85D7-7CCF7F50C614

Q37669469-1C36F52B-93AA-48AB-BD2D-6E60BC979D24

Q37669469-1E621C6C-A602-4AAD-B96A-011742533138

Q37669469-1F690161-DEAC-41D1-8C89-8E181CD3CC0C

Q37669469-21FC7652-5C8A-4C64-A07F-A83A0FF381AE

Q37669469-22567995-F305-4390-9ED9-5D4EEEDBC5A3

Q37669469-2A359A19-EBCF-486E-9621-4575DC2B42C9

Q37669469-2C0032DF-6DD9-42EC-BB32-E3BE39BAF16F

Q37669469-4BF728CF-BCEA-4D70-B4BB-E1284562B759

P304

Q37669469-BBB59D58-9F2A-4DEB-9319-B7E6D59FABD5

P31

Q37669469-32FA2FD5-E0DE-4016-AFE4-9C9DF64F84BE

P356

Q37669469-5C7F427F-7E58-4A24-85F7-ED42F1D0E60E

P407

Q37669469-973D365D-7BAE-4E48-AA0D-2C9E779FF221

P433

Q37669469-68D89F1C-A34C-4AF7-9920-679F45A4033D

P478

Q37669469-3853D904-7EEF-4921-B450-F7E854B44253

P50

Q37669469-0C6F98E9-8214-40B1-921A-CBED668B80DF

Q37669469-729A55DF-14EC-4C5D-9126-E0B2680AF868

Q37669469-7C78E653-5A38-4CEA-81AA-E8AC6B41B54E

Q37669469-ADB83F55-6022-4CDE-82BF-FD6301FE10DE

Q37669469-DE4EDEB5-67D4-4CC9-A648-35C51F0EA7A7

P577

Q37669469-521646B4-E5B8-4014-94B6-5C62A9EEDCDD

P698

Q37669469-45BCB5F1-C05C-4F8E-A3BE-8557A61A4897

P932

Q37669469-45F91B53-DCBF-41F7-BFAE-901F08AD0FC7

P356

JOURNAL.PONE.0169962

P1433

P1476

Medico-economic impact of MSKC ...... HER2-negative breast cancers.

@en

P2093

Brigitte Sigal-Zafrani

http://www.w3.org/2001/XMLSchema#string

Delphine Mouttet-Boizat

http://www.w3.org/2001/XMLSchema#string

Denise Stevens

http://www.w3.org/2001/XMLSchema#string

Eugénie Guillot

http://www.w3.org/2001/XMLSchema#string

Fabien Reyal

http://www.w3.org/2001/XMLSchema#string

Florence Lerebours

http://www.w3.org/2001/XMLSchema#string

François Campana

http://www.w3.org/2001/XMLSchema#string

Hélène Bonsang-Kitzis

http://www.w3.org/2001/XMLSchema#string

Jean-Guillaume Feron

http://www.w3.org/2001/XMLSchema#string

Jean-Yves Pierga

http://www.w3.org/2001/XMLSchema#string

P2860

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines.

Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification.

Factors affecting metastases to non-sentinel lymph nodes in breast cancer

Nonsentinel lymph node status after positive sentinel lymph node biopsy in early breast cancer.

Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection.

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial

Which nomogram is best for predicting non-sentinel lymph node metastasis in breast cancer patients? A meta-analysis.

Revision of the American Joint Committee on Cancer staging system for breast cancer.

P304

e0169962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0169962

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Anne Vincent-Salomon

Hélène Bonsang-Kitzis

Brigitte Sigal-Zafrani

P577

2017-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28241044

http://www.w3.org/2001/XMLSchema#string

P932

5328272

http://www.w3.org/2001/XMLSchema#string